AN2 Therapeutics
ANTX
#8920
Rank
A$0.29 B
Marketcap
A$7.67
Share price
-2.68%
Change (1 day)
354.74%
Change (1 year)

Earnings for AN2 Therapeutics (ANTX)

Earnings in 2026 (TTM): -A$57.23 Million

According to AN2 Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$57.58 Million, an increase over its 2024 earnings that were of -A$82.43 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AN2 Therapeutics from 2021 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$57.23 Million-0.61%
2025 -A$57.58 Million-30.14%
2024 -A$82.43 Million-21.66%
2023 -A$0.11 Billion64.77%
2022 -A$63.85 Million95.89%
2021 -A$32.6 Million